Article
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.
Tissue antigens - 1 Dec 1998
Benitez R, Godelaine D, Lopez-Nevot M A, Brasseur F, Jiménez P, Marchand M, Oliva M R, van Baren N, Cabrera T, Andry G, Landry C, Ruiz-Cabello F, Boon T, Garrido F
Abstract excerpt
Mutations have been identified in the beta2-microglobulin gene of tumor cells of two metastatic melanoma patients who received immunizations with MAGE peptides. One mutation abolishes the start codon whereas the other introduces a premature stop codon. The second beta2-microglobulin allele of bot...
Topics
- Antigens, Neoplasm
- Base Sequence
- Cancer Vaccines
- Female
- Histocompatibility Antigens Class I
- Humans
- Melanoma
- Melanoma-Specific Antigens
- Molecular Sequence Data
- Mutation
- Neoplasm Proteins
